Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential.

Exp Hematol Oncol · 2025 · PMC12046748 · PMID 40317077

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

did not reach statistical significanceP = 0.075so close (0.05 < p ≤ 0.1)

However, the difference did not reach statistical significance ( P = 0.075) [ 78 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.